IL2 and neoplasm: In contrast to the CEA-IL-2 wild-type form, CEA-IL-2v in animal models induces preferential expansion of CD8+ T and NK cells in blood, lymphoid tissues, and tumors and increases the number of tumor-infiltrating immune cells.